l carnitine lp a L-Carnitine: An Overview L-Carnitine - Arazo Nutrition

reported that a low molecular weight compound, 32-134D, effectively inhibits both HIF-1 and HIF-2 in an in vitro hepatocellular carcinoma model

Neurotensin and CRH interactions augment human mast cell activation

While Phase II trials in heart failure and primary mitochondrial myopathy did not meet primary efficacy endpoints, the TAZPOWER trial in Barth syndrome demonstrated significant improvements in muscle strength and sixminute walk distance, leading to FDA accelerated approval in 2025 [3][10]

Abstract Background: Stem cell technology is a promising research area with a potential to create effective therapies for many degenerative diseases